MedTrace Logo

Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer

NCT04938986 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-04-13

No results posted yet for this study

Summary

Evaluate the patient care recommandation induced by the IMMUNOSCORE® result

Conditions

  • Non Metastatic Colorectal Cancer

Interventions

DIAGNOSTIC_TEST

IMMUNOSCORE®

recommendation for patient care according to the result of the IMMUNOSCORE®

Sponsors & Collaborators

  • Hospital St. Joseph, Marseille, France

    lead OTHER

Principal Investigators

  • Hervé PERRIER, M.D · Hopital Saint Joseph Marseille

  • Yves RINALDI, M.D · Hopital Européen Marseille

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-04
Primary Completion
2028-04-30
Completion
2028-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04938986 on ClinicalTrials.gov